Gene expression profiling in biopsied tumor tissues

Details Gene expression profiling in biopsied tumor tissues Gene expression profiling in biopsied tumor tissues

2006-06-09

2011-12-06

Shaw, Amanda (Department: 1634)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

C435S091200, C536S024300, C536S023100

Reexamination Certificate

active

08071286

ABSTRACT:
The invention concerns sensitive methods to measure mRNA levels in biopsied tumor tissues, including archived paraffin-embedded biopsy material. The invention also concerns breast cancer gene sets important in the diagnosis and treatment of breast cancer, and methods for assigning the most optimal treatment options to breast cancer patient based upon knowledge derived from gene expression studies.

REFERENCES:
patent: 4699877 (1987-10-01), Cline et al.
patent: 5015568 (1991-05-01), Tsujimoto et al.
patent: 5459251 (1995-10-01), Tsujimoto et al.
patent: 5563035 (1996-10-01), Weigel
patent: RE35491 (1997-04-01), Cline et al.
patent: 5858678 (1999-01-01), Chinnadurai
patent: 5952179 (1999-09-01), Chinnadurai
patent: 5985553 (1999-11-01), King et al.
patent: 6180333 (2001-01-01), Giordano
patent: 6207452 (2001-03-01), Govindaswamy
patent: 6271002 (2001-08-01), Linsley et al.
patent: 6316208 (2001-11-01), Roberts et al.
patent: 6322986 (2001-11-01), Ross
patent: 6331396 (2001-12-01), Silverman et al.
patent: 6414134 (2002-07-01), Reed
patent: 6582919 (2003-06-01), Danenberg
patent: 6602670 (2003-08-01), Danenberg
patent: 6618679 (2003-09-01), Loehrlein et al.
patent: 6647341 (2003-11-01), Golub et al.
patent: 7081340 (2006-07-01), Baker et al.
patent: 2002/0009736 (2002-01-01), Wang
patent: 2002/0194022 (2002-12-01), Comite
patent: 2003/0073112 (2003-04-01), Zhang et al.
patent: 2003/0104499 (2003-06-01), Pressman et al.
patent: 2003/0165952 (2003-09-01), Linnarsson et al.
patent: 2003/0180791 (2003-09-01), Chinnadurai
patent: 2003/0198970 (2003-10-01), Roberts
patent: 2004/0009489 (2004-01-01), Golub et al.
patent: 2004/0133352 (2004-07-01), Bevilacqua et al.
patent: 2004/0209290 (2004-10-01), Cobleigh et al.
patent: 2006/0286565 (2006-12-01), Baker et al.
patent: 2007/0059737 (2007-03-01), Baker et al.
patent: 2007/0065846 (2007-03-01), Baker et al.
patent: 2007/0141587 (2007-06-01), Baker et al.
patent: 2007/0141588 (2007-06-01), Baker et al.
patent: 2007/0141589 (2007-06-01), Baker et al.
patent: 2007/0275398 (2007-11-01), Kiefer et al.
patent: 0 108 564 (1988-05-01), None
patent: 1 365 034 (2003-11-01), None
patent: WO 98/33450 (1998-08-01), None
patent: WO 99/02714 (1999-01-01), None
patent: WO 00/50595 (2000-08-01), None
patent: WO 00/55173 (2000-09-01), None
patent: WO 00/55629 (2000-09-01), None
patent: WO 00/60076 (2000-10-01), None
patent: WO 01/04343 (2001-01-01), None
patent: WO 01/25250 (2001-04-01), None
patent: WO 01/40466 (2001-06-01), None
patent: WO 01/40517 (2001-06-01), None
patent: WO 01/55320 (2001-08-01), None
patent: WO 01/70979 (2001-09-01), None
patent: WO 02/00677 (2002-01-01), None
patent: WO 02/06526 (2002-01-01), None
patent: WO 02/08260 (2002-01-01), None
patent: WO 02/08261 (2002-01-01), None
patent: WO 02/08282 (2002-01-01), None
patent: WO 02/08765 (2002-01-01), None
patent: WO 02/10436 (2002-02-01), None
patent: WO 02/46467 (2002-06-01), None
patent: WO 02/017852 (2002-07-01), None
patent: WO 02/055988 (2002-07-01), None
patent: WO 02/059271 (2002-08-01), None
patent: WO 02/059377 (2002-08-01), None
patent: WO 02/068579 (2002-09-01), None
patent: WO 02/103320 (2002-12-01), None
patent: WO 03/011897 (2003-02-01), None
patent: WO 03/083096 (2003-10-01), None
Wu, Thomas. Analyzing gene expression data from DNA microarrays to identify candidate genes. 2001. Journal of Pathology. vol. 195 pp. 53-65.
Lucentini, Jack. Gene Association Studies Typically Wrong. 2004. The Scientist vol. 18, pp. 1-3.
Miyoshi, Yasuo et al. Association of centrosomal kinase STK15?BTAK mRNA expression with chromosomal instability in human breast cancers. 2001. International Journal of Cancer. vol. 92 pp. 370-373.
Unger, Meredith et al. Characterization of adjacent breast tumors using oliognucleotide microarrays. 2001 Breast Cancer Research vol. 3 pp. 336-341.
Specht, Katja et al. Quantiative gene expression analysis in microdissected archival formalin fixed and paraffin embedded tumor tissue. 2001. American Journal of Pathology. vol. 158 pp. 419-429.
Sorlie, Therese. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. 2001. PNAS vol. 98 pp. 10869-10874.
Dialyna, Ioanna et al. Genetic polymorphisms and transcriptional pattern analysis of CYP1A1, AhR, GSTM1, GSTP1, and GSTT1 genes in breast cancer. 2001 International Journal of Molecular Medicine. vol. 9 pp. 79-87.
Chan, Eric. Integrating Transcriptomics and Proteomics. 2006. Genomics and Proteomics, avaliable online from www.genpromag.com, pp. 1-6.
Schmittgen, Thomas, et al. Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patients. 2003 International Jouranl of Cancer. vol. 107 pp. 323-329.
The Gene Card for ESR1 found online at http://www.genecards.org/cgi-bin/carddisp.pl?gene=ESR1&search=esr1 accessed Mar. 6, 2009.
The Gene Card for GSTM1 found online at http://www.genecards.org/cgi-bin/carddisp.pl?gene=GSTM1&search=gstm1 accessed Mar. 6, 2009.
Ambrosone, Christine et al. Polymoprhisms in glutathione s-transferases (GSTM1 and GSTT1) and survival after treatment for breast cancer. 2001. Cancer Research vol. 61 pp. 7130-7135.
Lizard-Nacol, Sarab et al. Glutathione s-transferase M1 null genotype: lack of assoication with tumor characteristics and survival in advanced breast cancer. 1999. Breast Cancer Research vol. 1 No. 1, pp. 81-87.
Khedhaier, A et al. Glutathione s-transferases (GSTT1 and GSTM1) gene deletions in Tunisians: susceptibility and prognositc implications in breast carcinoma. 2003 British Journal of Cancer vol. 89 pp. 1502-1507.
Le, Monique et al. c-myc, p53, and bcl2 Apoptosis related genes in infiltrating breast carcinomas: evidence of a link between bcl-2 protein over expression and a lower risk of metastasis and death in operable patients. Int Journal of Cancer. 1999 vol. 84 pp. 562-567.
GenBank Accession No. NM—022114.3 GI 289547572 Sep. 26, 2010.
GenBank Accession No. NM—001172675.1 GI 289547704 May 7, 2010.
GenBank Accession No. NM—014141.5 GI 289802978 Sep. 26, 2010.
GenBank Accession J03817 GI: 183668 Jan. 9, 1995.
Affymetrix Inc.: “Affymetrix GeneChip Human Genome U95 Version 2 Set HG-U95 A,”GEO, XX, XX, 1-243 (2002).
Bhattacharjee et al., “Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses”, Proceedings of the National Academy of Sciences of USA, vol. 98, No. 24. pp. 13790-13795 (2001).
Chang, J. et al., “Biologic Markers as Predictors of Clinical Outcome from Systemic Therapy for Primary Operable Breast Cancer,”Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, vol, 17:(10) 3058-3063 (1999).
Chen-Hsiang Yeang et al., “Molecular Classification of Multiple Tumor Types”, Bioinformatics, vol. 17, Suppl. 1, pp. S316-S322 (2001).
Cox, G. et al., “Bcl-2 is an Independent Prognostic Factor and Adds to a Biological Model for Predicting Outcome in Operable Non-Small Cell Lung Cancer,”Lung Cancer, vol. 34:(3) 417-426 (2001).
Dijkema, I.M. et al., “Influence of p53 and bcl-2 on Proliferative Activity and Treatment Outcome in head and Neck Cancer Patients,”Oral Oncology, Elsevier Science, vol. 36:(1) 54-60 (2000).
Golub et al., “Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring”, Science, vol. 286, pp. 531-537 (1999).
Guerin, M. et al., “Structure and Expression of C-ERBB-2 and EGF Receptor Genes in Inflammatory and Non-Inflammatory Breast Cancer: Prognostic Significance,”International Journal of Cancer, vol, 43 201-208 (1989).
Joensuu, H. et al., “Bcl-2 Protein Expression and Long-Term Survival in Breast Cancer,”American Journal of Pathology, vol. 145:(5) 1191-1198 (1994).
Kymionis, G.D., et al., “Can Expression of Apoptosis Genes, bcl-2 and Bax, Predict Survival and Responsiveness to Chemotherapy in Node-Negative Breast Cancer Patients?”The Journal of Surgical Research, vol.

Affiliated with

Also associated with

Rating

Gene expression profiling in biopsied tumor tissues does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Gene expression profiling in biopsied tumor tissues, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gene expression profiling in biopsied tumor tissues will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4299351